T2DM affects over 200 million people worldwide and is defined as a sustained state of hyperglycaemia due to dysfunction of insulin receptor (IR) signalling (insulin resistance) despite elevated levels of insulin (Ahmed, 2012). The gene discussed is INS; the disease is Insulin resistance.